Endocuff Vision 对软式乙状结肠镜筛查腺瘤检出率的影响:B-ADENOMA 随机对照试验
B-ADENOMA 研究在 16 家英国 BowelScope 筛查中心随机纳入 3222 名受试者,比较 Endocuff Vision 辅助软式乙状结肠镜(EAB)与标准软式乙状结肠镜(SB)的腺瘤检出率(ADR)。EAB 组 ADR 为 13.3%,SB 组为 12.2%(p=0.353),差异无统计学意义;SB 组 ADR 较全国 BowelScope ADR 高 3.1%。
要点
- Endocuff Vision 未提高软式乙状结肠镜筛查中的腺瘤检出率。
- 两臂在息肉检出率、平均腺瘤数、息肉特征及位置、受试者体验、并发症或操作特征上均无显著差异。
- 在检出率已较高的背景下,Endocuff Vision 无法进一步提升检出。
核心结论
- 与标准软式乙状结肠镜相比,Endocuff Vision 辅助并未改善 BowelScope 筛查的腺瘤检出率。
- 两臂 ADR 均高于全国 BowelScope ADR,提示在检出率已较高时 Endocuff Vision 无法进一步提升检出。
研究设计与样本
- B-ADENOMA 为多中心、随机对照试验,涉及 16 家英国 BowelScope 筛查中心。
- 共随机分配 3222 名受试者(53% 男性)至 Endocuff Vision 辅助 BowelScope(EAB,n=1610)或标准 BowelScope(SB,n=1612)。
- 两组基线人口学特征可比。
- 测量指标包括 ADR、息肉检出率(PDR)、平均每次操作腺瘤数(MAP)、息肉特征与位置、受试者体验、操作时间及不良事件,并将试验内 ADR 与全国 BowelScope ADR 进行比较。
主要发现
- EAB 组 ADR 为 13.3%,SB 组为 12.2%(p=0.353)。
- PDR、MAP、息肉特征或位置、受试者体验、并发症或操作特征均无统计学显著差异。
- SB 对照组 ADR 较全国 ADR 高 3.1%。
临床怎么用
- 在软式乙状结肠镜筛查中,不应常规期望通过加用 Endocuff Vision 来提高腺瘤检出率。
- 当筛查中心腺瘤检出率已高于全国水平时,引入 Endocuff Vision 的额外获益可能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Adenoma detection rate (ADR) is an important quality marker at lower GI endoscopy. Higher ADRs are associated with lower postcolonoscopy colorectal cancer rates. The English flexible sigmoidoscopy (FS) screening programme (BowelScope), offers a one-off FS to individuals aged 55 years. However, variation in ADR exists. Large studies have demonstrated improved ADR using Endocuff Vision (EV) within colonoscopy screening, but there are no studies within FS. We sought to test the effect of EV on ADR in a national FS screening population. DESIGN: BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities was a multicentre, randomised controlled trial involving 16 English BowelScope screening centres. Individuals were randomised to Endocuff Vision-assisted BowelScope (EAB) or Standard BowelScope (SB). ADR, polyp detection rate (PDR), mean adenomas per procedure (MAP), polyp characteristics and location, participant experience, procedural time and adverse events were measured. Comparison of ADR within the trial with national BowelScope ADR was also undertaken. RESULTS: 3222 participants were randomised (53% male) to receive EAB (n=1610) or SB (n=1612). Baseline demographics were comparable between arms. ADR in the EAB arm was 13.3% and that in the SB arm was 12.2% (p=0.353). No statistically significant differences were found in PDR, MAP, polyp characteristics or location, participant experience, complications or procedural characteristics. ADR in the SB control arm was 3.1% higher than the national ADR. CONCLUSION: EV did not improve BowelScope ADR when compared with SB. ADR in both arms was higher than the national ADR. Where detection rates are already high, EV is unable to improve detection further. TRIAL REGISTRATION NUMBERS: NCT03072472, ISRCTN30005319 and CPMS ID 33224.
引用
- Rees CJ, Brand A, Ngu WS, et al. BowelScope: Accuracy of Detection Using Endocuff Optimisation of Mucosal Abnormalities (the B-ADENOMA Study): a multicentre, randomised controlled flexible sigmoidoscopy trial. Gut. 2020. PMID: 32245908. doi:10.1136/gutjnl-2019-319621
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。